Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience.

Saved in:
Bibliographic Details
Title: Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience.
Authors: Shields AM; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.; Department of Clinical Immunology, University Hospitals Birmingham National Health Service (NHS) Foundation Trust, Birmingham, United Kingdom., Tadros S; Department of Immunology, Royal Free London National Health Service (NHS) Foundation Trust, London, United Kingdom., Al-Hakim A; Department of Allergy and Clinical Immunology, Leeds Teaching Hospitals National Health Service (NHS) Trust, Leeds, United Kingdom., Nell JM; Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals National Health Service (NHS) Foundation Trust and Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Lin MMN; Department of Immunology, Royal Free London National Health Service (NHS) Foundation Trust, London, United Kingdom., Chan M; Department of Immunology, Royal Free London National Health Service (NHS) Foundation Trust, London, United Kingdom., Goddard S; Department of Clinical Immunology, University Hospitals North Midlands, Stoke-on-Trent, United Kingdom., Dempster J; Department of Clinical Immunology, University College London Hospital National Health Service (NHS) Foundation Trust, London, United Kingdom., Dziadzio M; Department of Clinical Immunology, University College London Hospital National Health Service (NHS) Foundation Trust, London, United Kingdom., Patel SY; National Institute for Health and Care Research (NIHR) Biomedical Research Centre (BRC) Oxford Biomedical Centre, University of Oxford, Oxford, United Kingdom.; Department of Clinical Immunology, Oxford University Hospitals National Health Service (NHS) Foundation Trust, Oxford, United Kingdom., Elkalifa S; Department of Immunology, Salford Royal National Health Service (NHS) Foundation Trust, Salford, United Kingdom., Huissoon A; Department of Clinical Immunology, University Hospitals Birmingham National Health Service (NHS) Foundation Trust, Birmingham, United Kingdom., Duncan CJA; Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals National Health Service (NHS) Foundation Trust and Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Herwadkar A; Department of Immunology, Salford Royal National Health Service (NHS) Foundation Trust, Salford, United Kingdom., Khan S; Department of Clinical Immunology, Hull University Teaching Hospitals National Health Service (NHS) Trust, Hull, United Kingdom., Bethune C; Department of Allergy and Clinical Immunology, University Hospitals Plymouth National Health Service (NHS) Trust, Plymouth, United Kingdom., Elcombe S; Department of Allergy and Clinical Immunology, Newcastle upon Tyne Hospitals National Health Service (NHS) Foundation Trust, Newcastle upon Tyne, Newcastle, United Kingdom., Thaventhiran J; Medical Research Council Toxicology Unit, University of Cambridge, Cambridge, United Kingdom., Klenerman P; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Lowe DM; Department of Immunology, Royal Free London National Health Service (NHS) Foundation Trust, London, United Kingdom.; Institute of Immunity and Transplantation, University College London, London, United Kingdom., Savic S; Department of Allergy and Clinical Immunology, Leeds Teaching Hospitals National Health Service (NHS) Trust, Leeds, United Kingdom., Burns SO; Department of Immunology, Royal Free London National Health Service (NHS) Foundation Trust, London, United Kingdom.; Institute of Immunity and Transplantation, University College London, London, United Kingdom., Richter AG; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.; Department of Clinical Immunology, University Hospitals Birmingham National Health Service (NHS) Foundation Trust, Birmingham, United Kingdom.
Source: Frontiers in immunology [Front Immunol] 2022 Sep 23; Vol. 13, pp. 984376. Date of Electronic Publication: 2022 Sep 23 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2022.984376